• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROCTER & GAMBLE HEALTH CARE THERMACARE HEATWRAP; DISPOSABLE PACK, HOT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROCTER & GAMBLE HEALTH CARE THERMACARE HEATWRAP; DISPOSABLE PACK, HOT Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Hemorrhage/Bleeding (1888); Pain (1994); Scar Tissue (2060); Skin Discoloration (2074); Swelling (2091); Urticaria (2278); Complaint, Ill-Defined (2331); Sleep Dysfunction (2517); Burn, Thermal (2530); Fluid Discharge (2686); Partial thickness (Second Degree) Burn (2694); Full thickness (Third Degree) Burn (2696)
Event Date 12/28/2002
Event Type  Injury  
Manufacturer Narrative
Company clinical evaluation comment: based on the information provided, the events burns second degree, burns third degree, hemorrhage, blisters, and wound oozing as described in this case are considered serious bodily injury requiring medical intervention to prevent permanent damage or impairment of body structure, assessed as associated with the use of the device.The other events thermal burn, urticarial, pain, insomnia, swelling, skin disorder, keloid scar, skin discoloration, drug administration error are assessed as associated with the device.This case meets initial 10-day eu and 30-day fda reportability.Case comment: based on the information provided, the events burns second degree, burns third degree, hemorrhage, blisters, and wound oozing as described in this case are considered serious bodily injury requiring medical intervention to prevent permanent damage or impairment of body structure, assessed as associated with the use of the device.The other events thermal burn, urticarial, pain, insomnia, swelling, skin disorder, keloid scar, skin discoloration, drug administration error are assessed as associated with the device.This case meets initial 10-day eu and 30-day fda reportability.
 
Event Description
Third degree burns [burns third degree].Second degree burn [burns second degree].Bleeding [haemorrhage].Blisters on back/ 4 blisters about the size of dimes/ one of the blister's had fluid in it [blister].Burns oozing [wound secretion].Burn back [thermal burn].Welts on back [urticaria].Pain/burning pain on her back [pain].Can not sleep [insomnia].Drug misadministration (contra condition: new diabetic) [drug administration error].Swelling [swelling) pink flesh was exposed [skin disorder].Dark marks [skin discolouration].Starting to keloid [keloid scar].Case description: this is a spontaneous report from a contactable nurse.A (b)(6) black female patient started to receive thermacare heatwrap (thermacare heatwrap), topical on (b)(6) 2002 at 1 application once only for back pain.Medical history included drug hypersensitivity to darvon, darvocet, and chloromicidin, food allergy to shellfish, iv iodine allergy, diabetes mellitus non-insulin-dependent, arthritis, and high blood pressure.Consumer is a newfound diabetic but used product for 6-7 months with no problem.Concomitant medication included labetalol (labetalol), hydrochlorothiazide (hydrochlorothiazide), and lisinopril (lisinopril).On (b)(6) 2002, the patient applied one heatwrap for 3 hours and experienced second degree burn, burn back, blisters on back, 4 blisters about the size of dimes, one of the blister's had fluid in it and welts on back.On an unspecified date, the patient with diabetes mellitus used thermacare heatwrap and experienced pain/burning pain on her back, bleeding, third degree burns, burns oozing, swelling, pink flesh was exposed, dark marks, cannot sleep, and starting to keloid.Action taken in response to the events for thermacare heatwrap was permanently withdrawn on (b)(6) 2002.Therapeutic measures were taken as a result of the events included silvadene cream topically to the burn area and vicodin.The outcome of burns second degree, thermal burn, blister, urticarial, insomnia, drug administration error, swelling, skin disorder, wound oozing, haemorrhage, and burns third degree were recovered.The outcome of pain, skin discolouration, and keloid scar were not recovered.Follow-up (august 04, 2015): new information from the same nurse reporting for herself included: reaction data (events: third degree burns and bleeding, and event description: burning pain on her back, 4 blisters about the size of dimes, one of the blister's had fluid in it).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMACARE HEATWRAP
Type of Device
DISPOSABLE PACK, HOT
Manufacturer (Section D)
PROCTER & GAMBLE HEALTH CARE
albany GA
Manufacturer (Section G)
PFIZER CONSUMER HEALTH CARE
1231 wyandotte drive
albany GA 31705
Manufacturer Contact
219 east 42nd st.
new york, NY 10017
2127335544
MDR Report Key5010116
MDR Text Key23257482
Report Number1066015-2015-00102
Device Sequence Number1
Product Code IMD
Combination Product (y/n)N
PMA/PMN Number
K953442
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Report Date 12/30/2002
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Lay User/Patient
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/13/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
LABETALOL
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient Weight73
-
-